# Cynata Therapeutics Limited (CYYNF)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CYYNF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -2.66M | $ -2.39M | $ 0 | $ 3.39M |
| 2025 | $ 1.89M | $ -9.39M | $ -8.72M | $ 0 | $ 5.98M |
| 2024 | $ 2.37M | $ -9.98M | $ -10.20M | $ 0 | $ 7.22M |
| 2023 | $ 877.7K | $ -15.15M | $ -15.16M | $ 0 | $ 16.73M |
| 2022 | $ 4.41M | $ -6.18M | $ -3.75M | $ 0 | $ 23.96M |
| 2021 | $ 922.5K | $ -9.18M | $ -6.16M | $ 0 | $ 28.37M |
| 2020 | $ 4.23M | $ -4.39M | $ -4.09M | $ 0 | $ 16.79M |
| 2019 | $ 1.61M | $ -10.45M | $ -8.33M | $ 0 | $ 10.97M |
| 2018 | $ 1.72M | $ -5.71M | $ -5.08M | $ 0 | $ 15.39M |
| 2017 | $ 2.23M | $ -5.80M | $ -5.15M | $ 0 | $ 13.86M |
| 2016 | $ 1.43M | $ -6.42M | $ -5.66M | $ 0 | $ 8.58M |
| 2015 | $ 376.2K | $ -4.89M | $ -3.43M | $ 32.7K | $ 8.75M |
| 2014 | $ 33.5K | $ -4.06M | $ -2.47M | $ 0 | $ 9.85M |
| 2013 | $ 46.7K | $ -1.26M | $ -1.05M | $ 0 | $ 1.64M |
| 2012 | $ 228.8K | $ -2.17M | $ -1.1K | $ 0 | $ 853.8K |
| 2011 | $ 319.1K | $ -3.67M | $ -21.0K | $ 20.0K | $ 971.9K |
| 2010 | $ 168.3K | $ -3.13M | $ -134.7K | $ 0 | $ 932.0K |
| 2009 | $ 0 | $ -1.68M | $ -91.5K | $ 0 | $ 962.0K |
| 2008 | $ 546.2K | $ -2.32M | $ -64.2K | $ 0 | $ 2.21M |
| 2007 | N/A | N/A | N/A | $ 0 | $ 3.41M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.33 |
| Current Ratio | 2.49 |

## Other views

- [Metrics](https://sponda.capital/en/CYYNF.md)
- [Charts](https://sponda.capital/en/CYYNF/charts.md)
- [Compare](https://sponda.capital/en/CYYNF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.